Advent France Biotechnology becomes AdBio partners
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, is changing its company name to AdBio partners. The name change reflects the company’s expansion beyond France with UK-based partner Advent Life Sciences. AdBio Partners held the first close of its second fund at EUR86 million (USD102